Breast cancer recurrence and tumor size: A bibliometric analysis

Q4 Medicine Forum of Clinical Oncology Pub Date : 2024-07-18 DOI:10.2478/fco-2023-0025
Heba Ramadan
{"title":"Breast cancer recurrence and tumor size: A bibliometric analysis","authors":"Heba Ramadan","doi":"10.2478/fco-2023-0025","DOIUrl":null,"url":null,"abstract":"\n \n \n Breast cancer (BC) is the most common malignancy diagnosed in females. Over the years, many factors have been studied to understand what causes BC to come back. One of them is the tumor size at the beginning of the treatment. Tumor size is an interesting parameter, and some classifications of cancer grade depend on it.\n \n \n \n This bibliometric analysis examined the pattern followed by publications on BC recurrence and tumor size. The Scopus database was used, and bibliometric analysis was utilized to identify the most prolific authors, the journals most involved in the field, and the countries, institutions, and keywords used. BC recurrence and tumor size have an exponential growth in the number of publications over the years.\n \n \n \n For the last 11 years, from 2012 to 2022, the trend of annual publications concerning BC recurrence and tumor size increased dramatically, showing that the majority of publications were published in the United States (452 articles) by Morrow, M., who authored 13 articles; The University of Texas, Anderson Cancer Center had the most published articles (48 articles); and Breast Cancer Research and Treatment journal achieved the largest quantity of published articles (112 articles).\n \n \n \n Tumor size is an important risk factor for BC recurrence, and this bibliometric analysis focused on the high interest introduced by the research community.\n","PeriodicalId":38592,"journal":{"name":"Forum of Clinical Oncology","volume":" 6","pages":""},"PeriodicalIF":0.0000,"publicationDate":"2024-07-18","publicationTypes":"Journal Article","fieldsOfStudy":null,"isOpenAccess":false,"openAccessPdf":"","citationCount":"0","resultStr":null,"platform":"Semanticscholar","paperid":null,"PeriodicalName":"Forum of Clinical Oncology","FirstCategoryId":"1085","ListUrlMain":"https://doi.org/10.2478/fco-2023-0025","RegionNum":0,"RegionCategory":null,"ArticlePicture":[],"TitleCN":null,"AbstractTextCN":null,"PMCID":null,"EPubDate":"","PubModel":"","JCR":"Q4","JCRName":"Medicine","Score":null,"Total":0}
引用次数: 0

Abstract

Breast cancer (BC) is the most common malignancy diagnosed in females. Over the years, many factors have been studied to understand what causes BC to come back. One of them is the tumor size at the beginning of the treatment. Tumor size is an interesting parameter, and some classifications of cancer grade depend on it. This bibliometric analysis examined the pattern followed by publications on BC recurrence and tumor size. The Scopus database was used, and bibliometric analysis was utilized to identify the most prolific authors, the journals most involved in the field, and the countries, institutions, and keywords used. BC recurrence and tumor size have an exponential growth in the number of publications over the years. For the last 11 years, from 2012 to 2022, the trend of annual publications concerning BC recurrence and tumor size increased dramatically, showing that the majority of publications were published in the United States (452 articles) by Morrow, M., who authored 13 articles; The University of Texas, Anderson Cancer Center had the most published articles (48 articles); and Breast Cancer Research and Treatment journal achieved the largest quantity of published articles (112 articles). Tumor size is an important risk factor for BC recurrence, and this bibliometric analysis focused on the high interest introduced by the research community.
查看原文
分享 分享
微信好友 朋友圈 QQ好友 复制链接
本刊更多论文
乳腺癌复发与肿瘤大小:文献计量分析
乳腺癌(BC)是女性最常见的恶性肿瘤。多年来,人们对许多因素进行了研究,以了解导致乳腺癌复发的原因。其中之一就是治疗初期的肿瘤大小。肿瘤大小是一个有趣的参数,一些癌症等级的划分也取决于此。 本文献计量学分析研究了有关BC复发和肿瘤大小的出版物所遵循的模式。我们使用了 Scopus 数据库,并通过文献计量分析确定了最多产的作者、该领域涉及最多的期刊以及所使用的国家、机构和关键词。多年来,乳腺癌复发和肿瘤大小的论文数量呈指数增长。 从2012年到2022年的过去11年中,有关BC复发和肿瘤大小的年度论文数量呈急剧增长趋势,显示大部分论文发表在美国(452篇),其中Morrow, M.撰写了13篇文章;德克萨斯大学安德森癌症中心发表的文章最多(48篇);《乳腺癌研究与治疗》杂志发表的文章数量最多(112篇)。 肿瘤大小是乳腺癌复发的一个重要风险因素,这项文献计量分析的重点是研究界高度关注的问题。
本文章由计算机程序翻译,如有差异,请以英文原文为准。
求助全文
约1分钟内获得全文 去求助
来源期刊
Forum of Clinical Oncology
Forum of Clinical Oncology Medicine-Oncology
CiteScore
0.50
自引率
0.00%
发文量
3
审稿时长
6 weeks
期刊最新文献
Breast cancer recurrence and tumor size: A bibliometric analysis Outcomes of patients with localized prostate cancer treated with combined external beam radiotherapy and high-dose-rate brachytherapy boost: A single-center retrospective study Glomerulonephritis as a paraneoplastic event from prostate cancer relapse Change of dosing paradigm in oncology Total neoadjuvant therapy in rectal cancer: a review across studies
×
引用
GB/T 7714-2015
复制
MLA
复制
APA
复制
导出至
BibTeX EndNote RefMan NoteFirst NoteExpress
×
×
提示
您的信息不完整,为了账户安全,请先补充。
现在去补充
×
提示
您因"违规操作"
具体请查看互助需知
我知道了
×
提示
现在去查看 取消
×
提示
确定
0
微信
客服QQ
Book学术公众号 扫码关注我们
反馈
×
意见反馈
请填写您的意见或建议
请填写您的手机或邮箱
已复制链接
已复制链接
快去分享给好友吧!
我知道了
×
扫码分享
扫码分享
Book学术官方微信
Book学术文献互助
Book学术文献互助群
群 号:481959085
Book学术
文献互助 智能选刊 最新文献 互助须知 联系我们:info@booksci.cn
Book学术提供免费学术资源搜索服务,方便国内外学者检索中英文文献。致力于提供最便捷和优质的服务体验。
Copyright © 2023 Book学术 All rights reserved.
ghs 京公网安备 11010802042870号 京ICP备2023020795号-1